Navigation Links
FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause
Date:11/13/2008

PREMARIN (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE).

COLLEGEVILLE, Pa. (Business Wire EON) November 13, 2008 -- "This approval is welcome news, especially when you consider that more than one in four untreated postmenopausal women experience dyspareunia, a symptom of vulvar and vaginal atrophy, which typically does not subside without treatment," says Gloria Bachmann, M.D., Director of the Women's Health Institute at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, N.J. and Chief of the OB/GYN service at the teaching hospital.

PREMARIN Vaginal Cream is the first vaginal estrogen therapy indicated for the treatment of moderate to severe dyspareunia due to menopause. A low-volume regimen of PREMARIN Vaginal Cream can treat painful intercourse due to menopause, restore vaginal tissue, and reverse changes in the vagina that occur with menopause.

The approval is based on efficacy results from a multicenter clinical study that included a 12-week randomized, double-blind placebo phase followed by a 40-week open-label phase. Results from the 12-week phase showed that both low-dose regimens of PREMARIN Vaginal Cream (0.5 g daily [21 days on/7 days off or twice weekly) significantly improved the dyspareunia score versus placebo at 12 weeks. In this study, dyspareunia was one of the most bothersome symptoms of vulvar and vaginal atrophy. Endometrial safety was assessed in women who completed the 52-week study period and had evaluable endometrial biopsies. There were no reports of endometrial hyperplasia or endometrial carcinoma in these women
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
2. Pennsylvania Insurance Department Approves Launch of Senior Health Care Oversight Trust
3. US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period
4. FDA Approves New Indication for Hospiras Precedex (Dexmedetomidine HCL) Injection
5. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
6. Kaiser Permanente Approves $12 Million in Community Benefit Grants in Third Quarter of 2008
7. Congress Sets New Course for Lung Cancer Research; Approves $20 Million for New Defense Department Program
8. FDA Approves Nasacort AQ(R) Nasal Spray for Children Aged 2-5 years old
9. ClearWay Minnesota(SM) Board Approves New Officers
10. FDA approves first drug for Huntingtons disease
11. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Greater awareness among parents and providers of the ... full term has decreased the practice in the United ... elective deliveries (EEDs) still occur too frequently. A ... as delivery before 39 weeks without medical or obstetrical ... and offers no benefit to mothers or infants. Leading ...
(Date:8/21/2014)... Steven Reinberg HealthDay ... An experimental drug shows promise in treating respiratory syncytial virus ... "We are finally making major progress in being able ... cause of serious viral pneumonia, second only to influenza virus," ... at the University of Tennessee College of Medicine in Memphis. ...
(Date:8/21/2014)... United Benefit Advisors (UBA), the nation’s ... to announce Trinity Benefit Advisors as its newest ... Benefit Advisors is a full service firm that ... Their consultative approach is comprised of four components: ... monitoring. Their dedication to effective results and absolute ...
(Date:8/21/2014)... stem cells (MSCs) are present in virtually every type ... after injury. But the theory that MSCs are released ... organ damage, and migrate to the site of injury, ... conclusive evidence to resolve the controversy over the mobilization ... study published in Stem Cells and Development , ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... American Corporate Health, was recently recognized as ... professionals in the field of workers’ compensation. ... Workers’ Compensation and Occupational Medicine Conference was ... attorneys, physicians, nurses, case managers, disability specialists, ...
Breaking Medicine News(10 mins):Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 3Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 2Health News:Trinity Benefit Advisors is the Latest Firm to Join United Benefit Advisors 3Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2
... of problems right away, study notes , THURSDAY, July 16 ... soldiers from the Iraq and Afghanistan wars seen at VA ... a new study shows. , Curiously, the researchers from the ... diagnoses were not made in the first year that a ...
... Cardinals, Wide-Receiver and Pro Bowl MVP Larry Fitzgerald Encourages Parents to Take Action ... The College of Optometrists in Vision Development (COVD) ... take to ensure their children aren,t struggling with reading and learning because of ... , "The public doesn,t realize that you need over 15 visual ...
... , White Paper Details "Unforeseen Benefits" of ... WASHINGTON, July 16 Treating Americans who are addicted to alcohol and ... over a decade, according to an analysis released today by the Closing ... The white paper, "Unforeseen Benefits: Addiction Treatment Reduces Health Care Costs," ...
... major form of the disease , THURSDAY, July 16 ... with a stray genetic process critical in the development and ... strategy, described by researchers from the University of Rochester in ... symptoms of the debilitating disease and even, in some cases, ...
... Governor Walker to join University of ... , SAN JOSE, Calif., July 16 Olene Walker has ... interview later this month will likely be the most compelling from the former Utah ... be sharing her personal struggle with a fatal lung disease. , ...
... Archer: "We,re Determined to Make the House Bill ... " , , WASHINGTON, July ... Archer today praised the House for introducing a health reform bill that delivers ... is designed to control costs and deliver quality affordable health care to all. She ...
Cached Medicine News:Health News:Many Veterans Need Mental Health Care 2Health News:Many Veterans Need Mental Health Care 3Health News:Many Veterans Need Mental Health Care 4Health News:Does Your Child Need Vision Therapy? 2Health News:Does Your Child Need Vision Therapy? 3Health News:Does Your Child Need Vision Therapy? 4Health News:Addiction Treatment Will Help Make Health Reform Affordable, New Analysis Shows 2Health News:Addiction Treatment Will Help Make Health Reform Affordable, New Analysis Shows 3Health News:Scientists Reverse Muscular Dystrophy in Mice 2Health News:Scientists Reverse Muscular Dystrophy in Mice 3Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 2Health News:Former Utah Governor to Talk About Her Battle With PF on ABC 4 Salt Lake City, July 22nd 3
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
(Date:8/21/2014)... PARK, N.J. , Aug. 21, 2014 /PRNewswire/ ... pharmacy group purchasing organization (GPO), is pleased to ... to collaborate on a host of innovative specialty ... help Aurora deliver enhanced therapy management services to ... Management (OTM) system. Aurora will use ...
(Date:8/21/2014)... 2014 Professional Compounding Centers of America ... awarding the three best scientific presentations at the ... . The Formulating Better Medicines for Children ... Athens, Greece , includes dozens of ... from which three winners will be selected by ...
Breaking Medicine Technology:BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2
... Nov. 5 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ... Trademark Office has issued a patent covering the approved ... treatment of phenylketonuria (PKU). The patent expires in ... based on the discovery that food increases the bioavailability ...
... Rochester Medical Corporation (Nasdaq: ROCM ) today announced ... 30, 2009. , The Company reported sales of $9,009,000 for ... of last year. The Company reported a quarterly net ... net income of $342,000 or $.03 per diluted share for ...
Cached Medicine Technology:United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food 2United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food 3United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food 4Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 2Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 3Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 4Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 5Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 6Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 7Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 8Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 9Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 10Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 11Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert 12
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: